Industry News
Merck develops new genome editing tool
Science and technology company Merck has developed a new genome editing tool that is said to make CRISPR more efficient, flexible and specific. [ + ]
PharmAust secures non-cancer patent
Australian-listed, clinical-stage oncology company PharmAust has secured a new patent in Australia covering the use of its lead drug for non-cancer applications, including neurodegenerative diseases, diabetes and age-related disorders. [ + ]
Join the search for exploding stars
The Australian National University (ANU) is inviting citizen scientists with an interest in astronomy to join a search for exploding stars called supernovae. [ + ]
Immunotherapy may increase tumour growth in some cases
Scientists have found that cancer immunotherapy, intended to boost the body's immune system in order to fight tumours, may actually be having the opposite effect in some cancers. [ + ]
'Tumour-trained' immune cells move from one tumour to another
Scientists at Sydney's Garvan Institute of Medical Research have discovered that 'tumour-trained' immune cells — which have the potential to kill cancer cells — move from one tumour to another. [ + ]
ACCSI award for GeoPyc 1365
The Annual Conference of China Scientific Instruments (ACCSI) has recognised the Micromeritics GeoPyc 1365 as one of the leading new instruments introduced in China in 2017. [ + ]
Australian researchers build brain-on-a-chip
Australian researchers have grown brain cells on a semiconductor wafer patterned with nanowires which act as a scaffold to guide the growth of brain cells. [ + ]
Avita Medical files IPR against Renovacare patent
Avita Medical Limited, a regenerative medicine company focused on the treatment of wounds and skin defects, has filed an Inter Partes Review (IPR) petition against Renovacare patent. [ + ]
Jumping without slipping: the secret of the leafhopper
UK researchers have uncovered the secret behind the explosive leaping ability of leafhopper insects — a discovery that could help create better technology in the future. [ + ]
Funding boost for clinical trials
The Australian Clinical Trials Alliance has welcomed the funding commitment for clinical trials and registries in the Federal Budget. [ + ]
Hall of Fame award for IDT Australia
Pharmaceutical manufacturing and drug development company IDT Australia has received a Victorian Manufacturing Hall of Fame award in the High Growth Sector of Medical Technologies and Pharmaceuticals. [ + ]
International funding for Australian epigenome researcher
Australian epigenetics and genomics researcher Ryan Lister has been chosen alongside 40 researchers from 16 countries to receive a prestigious international scholarship that will fund his research. [ + ]
Cannabis could reverse brain decline
Cannabis has the potential to reverse brain ageing and improve memory function, a new European study has revealed. [ + ]
Spinout company Exopharm to harness the regenerative power of exosomes
Altnia Group has spun out a new company called Exopharm as part of its efforts to bring a new type of nanodrug called exosomes into local clinical trials. [ + ]
Key China patent for PharmAust
PharmAust, an ASX-listed oncology company, has secured a key China patent. [ + ]
